C. Slabber

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning et al. · Annals of Oncology · 2005 · 222 citations · Full text

Medicine, Oncology, Pharmacology +10

A Randomized Study of Radiotherapy Alone Versus Radiotherapy Plus 5-Fluorouracil and Platinum in Patients With Inoperable, Locally Advanced Squamous Cancer of the Esophagus

C. Slabber, Johan S. Nel, L. Schoeman et al. · American Journal of Clinical Oncology · 1998 · 84 citations

Medicine, Oncology, Radiation Oncology +10

The RNA helicase DHX9 establishes nucleolar heterochromatin, and this activity is required for embryonic stem cell differentiation

Sergio Leone, Dominik Bär, C. Slabber et al. · EMBO Reports · 2017 · 53 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +14

First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study

Daniel Vorobiof, Bernardo L. Rapoport, Martin Chasen et al. · The Breast · 2004 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer

Bernardo L. Rapoport, Daniel Vorobiof, C. Slabber et al. · International Journal of Gynecological Cancer · 2009 · 22 citations

Medicine, Oncology, Pharmacology +17